Biotechnology Jobs in Cambridge

GSK · USA - Pennsylvania - Upper Providence · US$242,250 – US$403,750 pa

Leads the global development of a medicine from clinical Proof of Concept to approval in first major markets, acting as the single point of accountability. Builds and directs a matrixed Medicine Development Team spanning clinical, medical, commercial and manufacturing, and owns the asset budget and resourcing plan. Hybrid role requiring at least two days per week on-site at a US or UK GSK site.

GSK · Waltham, United States · US$242,250 – US$403,750 pa

Leads the global development of a medicine from clinical Proof of Concept through first major-market approval, acting as the single point of accountability. Builds and directs a matrixed Medicine Development Team spanning clinical, medical, commercial and manufacturing, and owns the asset's strategy, budget and governance decisions.

GSK · Durham Blackwell Street · US$188,100 – US$313,500 pa

Leads quantitative systems pharmacology and QST modelling within a clinical pharmacology and quantitative medicine group, building mechanistic models of disease and drug action and running simulations to assess trial design. Defines and coordinates MIDD strategies across respiratory, immunology and inflammation programmes, working with biologists, clinicians, pharmacometricians and AI/ML specialists. The role sits in a newly established Centre of Excellence for model-informed drug development.

GSK · Durham, United States · US$148,500 – US$336,875 pa

Drives the development and execution of the analytical network strategy across GSK's global supply chain, defining QC testing network principles and translating them into an operational roadmap. Partners with GSC Quality, MSAT, R&D and governance forums on NPI and commercial supply decisions, with a focus on large molecules, ADCs and oligonucleotides. Establishes KPIs and reporting to track strategy impact and mitigate network risk.

GSK · Waltham, United States · US$202,125 – US$336,875 pa

Drives the development and execution of the analytical/QC testing network strategy across GSK's global supply chain, translating approved strategy into operational roadmaps and securing governance endorsement. Partners with Quality, MSAT, R&D and product leads on NPI and commercial supply, benchmarks industry best practice, and builds KPI reporting and risk mitigation for large molecules, ADCs and Oligos.

GSK · London · US$202,125 – US$336,875 pa

Drives the development and execution of the analytical network strategy across GSK's supply chain, defining QC testing network principles and translating them into an operational roadmap. Partners with GSC Quality, MSAT, R&D and governance forums on NPI and commercial supply decisions, with a focus on large molecules, ADCs and oligonucleotides. Benchmarks industry practice and builds KPI reporting and capability within the GSC Strategy team.

GSK · Zebulon, United States · US$202,125 – US$336,875 pa

Drives the development and execution of the analytical/QC testing network strategy across the global supply chain, translating approved strategy into an operational roadmap and securing endorsement from governance forums such as the Supply Chain Review Board. Partners with GSC Quality, MSAT and R&D on NPI and commercial supply, benchmarks industry best practice, and builds KPI reporting for senior leadership. Focuses on analytical testing strategy for large molecules, ADCs and Oligos.

GSK · Upper Merion · US$202,125 – US$336,875 pa

Drives the development and execution of the analytical network strategy across GSK's supply chain, defining QC testing network principles and translating them into an operational roadmap. Collaborates with GSC Quality, MSAT and R&D, benchmarks industry best practice, and establishes KPIs and reporting for senior leadership. Focuses on analytical testing strategy for large molecules, ADCs and Oligos.

GSK · Belgium-Wavre · €148,500 – €247,500 pa

Drives the development and execution of the analytical network strategy across GSK's global supply chain, defining QC testing network principles and translating them into an operational roadmap. Acts as the single point of contact in GSC Strategy, collaborating with Quality, MSAT and R&D, benchmarking industry practice and reporting KPIs to senior leadership.

GSK · Waltham, United States · US$151,500 – US$252,500 pa

Leads cross-functional project teams within Oncology Translational Medicine, coordinating diagnostics, biomarker, clinical development, regulatory and finance activities across internal groups and external partners. Manages integrated timelines, budgets, contracts and invoices, tracks milestones and risks, and supports regulatory documentation and technical evaluations of diagnostic technologies.

GSK · Stevenage · US$151,500 – US$252,500 pa

Leads cross-functional project teams within Oncology Translational Medicine to progress diagnostic and biomarker development activities, coordinating with clinical, regulatory, quality, finance and external lab partners. Builds integrated timelines, tracks budgets, milestones and contracts, mitigates risks, and supports regulatory submissions and technical evaluations of diagnostic technologies.

GSK · Philadelphia, United States · US$203,775 – US$339,625 pa

Provides scientific and strategic leadership for real-world evidence supporting an mRNA vaccine portfolio, with a primary focus on influenza. Shapes evidence generation across late-stage development, launch and post-marketing, leading US post-marketing vaccine effectiveness studies and external academic and data-partner collaborations. Requires deep expertise in influenza epidemiology, real-world data and causal methods, plus influence across a global matrix.

GSK · Waltham, United States · US$203,775 – US$339,625 pa

Provides scientific and strategic leadership for real-world evidence supporting an mRNA vaccine portfolio, with a primary focus on influenza. Shapes evidence generation across late-stage development, launch and post-marketing, leading US post-marketing vaccine effectiveness studies and complex external collaborations with academic and healthcare data partners.

GSK · London · US$203,775 – US$339,625 pa

Provides scientific and strategic leadership for real-world evidence supporting an mRNA vaccine portfolio, with a primary focus on influenza. Shapes evidence generation across late-stage development, launch and post-marketing phases, leading US post-marketing vaccine effectiveness studies and complex external collaborations with academic and healthcare data partners.

GSK · Durham, United States · US$203,775 – US$339,625 pa

Leads the integrated real-world evidence and health outcomes strategy for mRNA influenza vaccines, designing and interpreting US post-marketing vaccine effectiveness studies across late-stage development, launch and post-marketing phases. Partners with clinical development, epidemiology, medical affairs, regulatory, biostatistics and market access teams, and builds collaborations with academic investigators, healthcare systems and data partners. Requires deep expertise in US vaccine effectiveness research, influenza epidemiology, real-world data and causal methods.